Industry › Healthcare & Pharm

Press Releases

Singapore cord blood bank Cryoviva establishes footprint in the UAE

Jul 27, 2021 08:00 HKT/SGT

Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma

Jul 23, 2021 08:17 HKT/SGT

사우스 오스트레일리아 주 총리, 아태 지역 임상 시험을 목적으로 150만 달러 규모의 백신 및 면역생물학 최첨단 연구소 발족

Jul 16, 2021 08:00 HKT/SGT

南オーストラリア州首相、150万ドルのワクチン・免疫生物学の最先端研究所を開所　アジア太平洋地域における臨床試験に対応

Jul 15, 2021 17:05 JST

行动基因香港实验室荣获CAP认证区内基因检测与科研能力进一步提升

Jul 15, 2021 16:27 HKT/SGT

行動基因香港實驗室榮獲CAP認證區內基因檢測與科研能力進一步提升

Jul 15, 2021 16:25 HKT/SGT

ACT Genomics Hong Kong Laboratory Earns CAP Accreditation, NGS Testing and R&D Capacity Strengthened

Jul 15, 2021 16:20 HKT/SGT

Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures

Jul 15, 2021 11:28 JST

Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures

Jul 15, 2021 10:25 HKT/SGT

南オーストラリア州首相、150万ドルのワクチン・免疫生物学の最先端研究所を開所　アジア太平洋地域における臨床試験に対応

Jul 15, 2021 07:00 JST

南澳大利亚州州长为亚太地区临床试验设立了价值 150 万美元的疫苗和免疫生物学一流实验室

Jul 15, 2021 07:00 HKT/SGT

南澳大利亞州州長為亞太地區臨床試驗設立了價值 150 萬美元的疫苗和免疫生物學一流實驗室

Jul 15, 2021 07:00 HKT/SGT

Premier of South Australia Launches $1.5m Vaccine and Immunobiology State-of-the art Laboratory for APAC Clinical Trials

Jul 14, 2021 17:00 HKT/SGT

Sri Trang Group accelerates Covid inoculation program

Jul 12, 2021 19:30 HKT/SGT

영국 의약품규제청, 코로나 사태 속 신속한 정기 검토를 위한 휴머니젠의 렌질루맙 마케팅 승인 신청을 승인

Jul 12, 2021 07:00 HKT/SGT

Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia

Jul 09, 2021 21:00 JST

Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia

Jul 09, 2021 20:00 HKT/SGT

医思健康进一步向策略性股东郑志刚博士及 Aspex Management 发行股份加强医疗地产化战略部署

Jul 09, 2021 08:32 HKT/SGT

醫思健康進一步向策略性股東鄭志剛博士及 Aspex Management 發行股份加強醫療地產化戰略部署

Jul 09, 2021 08:31 HKT/SGT

EC Healthcare Further Issue Shares to Strategic Shareholder Dr. Cheng Chi Kong and Aspex Management To Enhance Collaboration in Deploying Medical Real Estate Strategy

Jul 09, 2021 08:30 HKT/SGT